{"schema":"hottub-news/list/v1","item_schema":"hottub-news/item/v1","count":1,"sponsored":0,"items":[{"id":"n_slgsxgbjfizidemacw2q","seq":10939281,"kind":"article","title":"AZN : FDA Okays IMFINZI Combination Regimen For Cisplatin-Ineligible Muscle-Invasive Bladder Cancer","url":"https://www.finanzen.ch/nachrichten/aktien/azn-fda-okays-imfinzi-combination-regimen-for-cisplatin-ineligible-muscle-invasive-bladder-cancer-1036763892","published":"2026-11-14T02:23:00Z","seen":"2026-11-14T02:23:00Z","lang":"en","country":"CH","source":{"id":"finanzen.ch","name":"finanzen.ch","domain":"finanzen.ch"},"via":"gdelt-gkg-english","topics":["economy","health"],"entities":[{"id":"Q204711","name":"United States Food and Drug Administration","type":"org"},{"id":"Q19904005","name":"durvalumab","type":"other"},{"id":"Q412415","name":"cisplatin","type":"other"},{"id":"Q53620955","name":"Muscle-invasive bladder cancer","type":"other"}],"story":"st_quq3xk4j2o5k3r5ifd2a","category":"health","category_p":0.37,"sentiment":"neutral","tone":-0.18,"political":0.33}]}